Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-21

Clinical Trial Update: Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing trastuzumab versus observation in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trastuzumab (trastuzumab)

Snippet

Sponsor: University Hospital of Crete | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED